Lindi Chen

p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance

Lindi Chen, Deborah A. Tweddle · Frontiers in Oncology · 2012 · 42 citations · Full text

Immunology, Pathology, Cancer Biology +17

ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms

Harriet Southgate, Lindi Chen, Deborah A. Tweddle et al. · Cancers · 2020 · 34 citations · Full text

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Elizabeth R. Tucker, Irène Jiménez, Lindi Chen et al. · Clinical Cancer Research · 2023 · 30 citations · Full text

SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma

Laura Evans, Lindi Chen, Giorgio Milazzo et al. · Cancer Letters · 2015 · 22 citations

Potential Therapeutic Target, Cell Regulation, Glioma +7

Identification of different<i>ALK</i>mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

Lindi Chen, Angharad Humphreys, Lisa Turnbull et al. · Oncotarget · 2016 · 22 citations · Full text